Integrated molecular pathology and therapeutic outcomes in dermatofibrosarcoma protuberans: Ki-67, COL1A1::PDGFB, and efficacy of Mohs surgery with postoperative imatinib in 153 Chinese patients
Jinrui Guo, Yongmei Cui, Nana Zhang, Jing Liang, Jian-Ning Chen, Xiangqi Huang, Dan He
Springer Nature ·
2026-04-30
· DOI 10.1186/s12885-026-16090-3
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Jinrui Guo, Yongmei Cui, Nana Zhang, Jing Liang, Jian-Ning Chen, Xiangqi Huang et al. Integrated molecular pathology and therapeutic outcomes in dermatofibrosarcoma protuberans: Ki-67, COL1A1::PDGFB, and efficacy of Mohs surgery with postoperative imatinib in 153 Chinese patients. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-16090-3. – URL: https://doi.org/10.1186/s12885-026-16090-3
Jinrui Guo, Yongmei Cui, Nana Zhang, Jing Liang, Jian-Ning Chen, Xiangqi Huang, & Dan He (2026). Integrated molecular pathology and therapeutic outcomes in dermatofibrosarcoma protuberans: Ki-67, COL1A1::PDGFB, and efficacy of Mohs surgery with postoperative imatinib in 153 Chinese patients. BMC Cancer. https://doi.org/10.1186/s12885-026-16090-3
Jinrui Guo, et al. “Integrated molecular pathology and therapeutic outcomes in dermatofibrosarcoma protuberans: Ki-67, COL1A1::PDGFB, and efficacy of Mohs surgery with postoperative imatinib in 153 Chinese patients.” BMC Cancer, 2026. doi:10.1186/s12885-026-16090-3.
@article{Guo2026,
title = {Integrated molecular pathology and therapeutic outcomes in dermatofibrosarcoma protuberans: Ki-67, COL1A1::PDGFB, and efficacy of Mohs surgery with postoperative imatinib in 153 Chinese patients},
author = {Guo, Jinrui and Cui, Yongmei and Zhang, Nana and Liang, Jing and Chen, Jian-Ning and Huang, Xiangqi and He, Dan},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-16090-3},
url = {https://doi.org/10.1186/s12885-026-16090-3}
}